Breakthrough in delivery system technologies is crucial to drive innovation in the traditional vitamin and minerals category, as well as the booming probiotics, functional food and beverage sectors.
Ingredients with poor bioavailability, such as curcumin, can be applied in new nutraceutical product formats, including stick sachets, juice, and oral spray, with the use of advanced delivery technologies.
A self-emulsifying delivery system has shown to increase the blood plasma absorption of CoQ10 by three times more than that of a standard CoQ10 supplement.
Researchers from the Agency for Science, Technology and Research (A*STAR) Singapore have developed a new encapsulation technology that boosts the bioavailability of lactoferrin, a naturally occurring protein in human breast milk.
Indena is striving for APAC growth with market entry in Japan and China, and launching a more bioavailable formulation of coenzyme Q10 (CoQ10), which the firm believes has potential for success in sports nutrition and beyond.
Chinese supplement firm Thankcome Biological Science and Technology (Suzhou) has successfully developed and produced spore-forming bacteria for use as probiotics in food.
Read about advances in Omega-3 Index testing and plant-derived omega-3, watch our latest Nutrition Asia video on delivery system innovations, and grab your early bird tickets to our second Healthy Ageing APAC Summit.
Australian firms Entity Health and Pharmako Biotechnologies have identified the key factors supplement firms should consider when investing in delivery system innovation in APAC.
Asia is the region most ripe for omega-3 growth, providing the sector focuses on credibility, convenience, and delivery system innovation, according to François Scheffler, BASF's Senior Vice President of Global Human Nutrition.
The body's absorption of omega-3 increased by six times after taking a supplement that used the self micro-emulsifying delivery system (SMED) from Pharmako Biotechnologies, a series of human clinical trials conducted in Australia has found.
Pharmako Biotechnologies has had the patent for its LipiSperse technology approved by the World Intellectual Property Organization (WIPO), opening the door for the firm to develop novel formulations for lipid-soluble compounds.
When marketing probiotics, delivery system technology is still mostly a B2B tool, according to data from Lumina Intelligence. But as consumers scrutinize efficacy more, it may become an important marketing tool.